Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNU6ATAC23P is a pseudogene of a small nuclear RNA (snRNA) belonging to the U6atac family. Small nuclear RNAs are essential noncoding RNAs that normally function within the spliceosome, a complex responsible for removing introns from pre-mRNA. However, as a pseudogene, RNU6ATAC23P is typically not transcribed or does not give rise to a functional snRNA molecule and lacks known biological, clinical, or pharmacological relevance. Pseudogenes such as this are often genomic "relics" rather than active participants in cellular physiology. Additional Context: - U6atac snRNA: In general, the canonical U6atac snRNA is involved in the minor (U12-type) spliceosome, which processes a rare class of introns in eukaryotic genes. However, pseudogenes like RNU6ATAC23P do not contribute to this function. - Pseudogenes: Pseudogenes are gene remnants that have lost their original function through mutation. While some pseudogenes are occasionally transcribed and implicated in regulatory networks, most are not functionally relevant, especially as drug targets. - No evidence for targeting: There are no reports of drugs, diagnostic, or therapeutic applications involving this pseudogene. If you are seeking a functionally relevant, druggable target, the canonical U6atac snRNA may be of interest primarily for RNA biology, but not the RNU6ATAC23P pseudogene itself.
None
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6atac small nuclear 23, pseudogene (RNU6ATAC23P).